Antibiotic distribution and recovery in tissue
Project factsheets
Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).
Displaying 18 projects and 2 programmes
Antimicrobial Resistance Accelerator
Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections
Collaboration for prevention and treatment of MDR bacterial infections
European regimen accelerator for tuberculosis
Novel Gram-negative antibiotic now
Predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs
Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors
Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments
Academia and industry united innovation and treatment for tuberculosis
The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
Combatting bacterial resistance in Europe - molecules against Gram negative infections
Combatting Bacterial Resistance in Europe
Driving re-investment in R&D and responsible antibiotic use
European Gram-negative Antibacterial Engine
Inhaled antibiotics in bronchiectasis and cystic fibrosis
New Drugs for Bad Bugs
Molecular basis of the bacterial cell wall permeability
